Pembrolizumab with carboplatin and paclitaxel for untreated advanced or recurrent endometrial cancer [ID6381]

  • In development
  • GID-TA11461
  • Expected publication date: TBC

NIHRIO BN: 37144-Pembrolizumab-Chemotherapy-for-Endometrial-Cancer-V1.0-OCT2023-NON-CONF-.pdf (nihr.ac.uk)